U.S. market Closed. Opens in 2 hours 59 minutes

PRGO | Perrigo Company plc Stock Overview

(Stock Exchange: NYSE)
Day's Range 25.31 - 26.18
52 Week Range 23.89 - 34.60
Beta 0.47
Implied Volatility 67.07%
IV Rank 94.88%
Day's Volume 1,779,430
Average Volume 1,325,285
Shares Outstanding 136,415,000
Market Cap 3,466,305,150
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 1991-12-17
Valuation
Profitability
Growth
Health
P/E Ratio -30.61
Forward P/E Ratio N/A
EPS -0.83
1YR Price Target N/A
Dividend Yield 4.23%
Dividend Per Share 1.08
Dividend ExDate N/A
Dividend PayDate N/A
Employees 9,140
Country Ireland
Website PRGO
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
PRGO's peers: KMDA, PBH, AMPH, DCPH, PCRX, COLL, PAHC, ELAN, RDY, SSIC, EGRX, ANIP
*Chart delayed
Analyzing fundamentals for PRGO we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see PRGO Fundamentals page.

Watching at PRGO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on PRGO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙